Raglan Pharmaceutical & Life Science Projects

Raglan Capital is involved in a number of pharmaceutical and life science ventures including Amryt Pharma. Amryt Pharma is a specialty pharmaceutical company focused on the developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.

Amryt’s earlier stage products are focussed on developing novel, next generation somatostatin analogue (“SSA”) peptide medicines for patients with rare neuroendocrine diseases, where there is high unmet medical needs. These include acromegaly and Cushing's disease.

Amryt Pharma is listed on AIM and ESM. Further details can be found on www.amrytpharma.com

Raglan Natural Resources Projects

Originally named Terra Energy Limited, Terra completed a reverse take over of the AIM shell Sterling Green Group plc in May 2012 and was renamed Fastnet Oil and Gas plc. Fastnet Oil & Gas plc is an independent oil and gas exploration company focused on identifying early stage exploration and appraisal opportunities in Offshore Ireland and Africa.

The new Enlarged Group Fastnet Oil and Gas, is quoted on the AIM market of the London Stock Exchange and the Enterprise Securities Market (ESM) of the Irish Stock Exchange. Fastnet has its operating headquarters based in Dublin, Ireland.

For further information on Fastnet Oil and Gas please see www.fastnetoilandgas.com.

T5 Oil & Gas is a newly established and privately owned independent oil & gas exploration company, focused on identifying and acquiring highly prospective oil & gas assets, primarily in Africa. T5 was created and is led by five former Tullow Oil plc. directors with exceptional experience and track record in the oil and gas industry. T5's operations office is based in Dublin, Ireland.

The Company recently completed a successful pre-IPO fundraising of $8m and is targeting a listing on the AIM market of the London Stock Exchange.

For further information on T5 Oil and Gas please see www.t5oilandgas.com.